Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
vvYrAvXLmzphUSLa